Navigation Links
New Data Supports Significant Economic and Clinical Value of MENOPUR(R) in IVF
Date:6/30/2009

ropins in IVF and this work is likely to have a major impact on the decision-making process with respect to IVF treatment. The study showed that HP-hMG is a more attractive option than rFSH within a fixed budget, as it offers considerable cost savings over rFSH, not only in terms of costs per treatment cycle, but also in costs per live births."

Health economic data

The new study determined the cost-effectiveness of different gonadotropins in IVF cycles involving frozen embryo transfers using a simulation model. The economic evaluation compared HP-hMG and rFSH using individual patient data (n=986) pooled from two large, randomised, multi- national, non-inferiority trials (EISG[3] and MERiT[4])[5].

The simulation model used both live-birth data for the compared products and published UK costs of IVF related medical resources. The main objectives were to determine for each patient starting treatment consisting of one fresh and up to two cryo or fresh cycles: (1) number of live-births (2) average cost of treatment; (3) average cost per live-birth; (4) incremental cost-effectiveness; (5) impact of inclusion of maternal and neonatal costs arising from successful pregnancies.

After a sequence of one fresh and up to two frozen or fresh cycles, the cumulative live-birth rate was 53.7% for HP-hMG and 44.6% for rFSH (p<0.005). The use of HP-hMG resulted in a saving of GBP875 per patient cycle, a saving that could finance an additional treatment for every seven treatments delivered.[1] Furthermore, the cost per IVF baby delivered with HP-hMG was GBP11,157, compared with GBP14,227 for rFSH(p<0.001).[1]

Within the context of this economic analysis, HP-hMG offered a superior cost-effectiveness in producing live-births over rFSH in women undergoing conventional IVF and, when available, frozen embryo transfer cycles.[1] Since this study attempts to realistically model the actual situati
'/>"/>

SOURCE Ferring Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Study Supports Efficacy of Vagus Nerve Stimulation for Treatment-Resistant Depression
2. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
3. Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer
4. Cost-Effectiveness Study Supports Use of EUFLEXXA(TM) by Rheumatologists for Pain Relief in Patients with Knee Osteoarthritis
5. New Data from the Framingham Heart Study Supports PAT Technology to Diagnose Early Cardiovascular Disease
6. Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood
7. Interim Safety Analysis Supports Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma
8. Interim Analysis Supports Continuation of Cell Genesys VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
9. FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
10. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
11. New Clinical Data Further Supports Chromium Picolinates Role in Enhancing Brain Activity in Older Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... InformEx, North America,s leading business ... hold the 30 th edition of its annual conference ... from January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ) ... chemical and specialty chemical companies will take part in the ...
(Date:1/14/2014)... Dynamic Healthcare Services, Inc. ("DHS"), a portfolio company of GMH ... Medical Equipment, Inc. ("Progressive") of Clarion, PA ... were not disclosed. Progressive is a full ... of sleep, mobility, and respiratory products to customers in the ...
(Date:1/14/2014)... , Jan. 14, 2014 Animal Emergency Critical Care, a ... Leesburg, Virginia is the first in ... chamber. Dr. Susan M. Barnes , Medical ... Barnes and husband, Dr. Cole Taylor , are avid scuba ...
Breaking Medicine Technology:Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2
... , JAMESBURG, N.J. , April 28 Phytomedics Inc., ... consumer products solely derived from plant sources, today announced that Dr. ... corporate presentation at the BIO 2010 International Convention on Thursday, May ... , , , ...
... 28 Utilization of the FDA cleared Axxent® Electronic Brachytherapy, ... clinical experience demonstrates the isotope-free cancer treatment platform is a patient ... oncology applications at the 11th Annual Meeting of the American Society ... , , ...
Cached Medicine Technology:Phytomedics Inc. To Present at BIO 2010 International Convention 212 Month Follow-Up Data for Isotope-Free Breast IORT Presented at ASBS Meeting 212 Month Follow-Up Data for Isotope-Free Breast IORT Presented at ASBS Meeting 312 Month Follow-Up Data for Isotope-Free Breast IORT Presented at ASBS Meeting 4
(Date:4/18/2014)... Benaroya Research Institute at Virginia Mason (BRI) recently ... molecule in metastatic breast cancer reduces both the growth ... BRI scientists have found in models of the disease ... - 80 percent and can keep the tumor from ... five-year grant comes from the National Cancer Institute of ...
(Date:4/18/2014)... French . ... medicine. A team led by Ludwik Leibler from the ... Didier Letourneur from the Laboratoire Recherche Vasculaire Translationnelle (INSERM/Universits ... the principle of adhesion by aqueous solutions of nanoparticles ... and tissues. This easy-to-use gluing method has been tested ...
(Date:4/17/2014)... chronic inflammation in non-cancerous prostate tissue may have nearly ... those with no inflammation, according to results of a ... Kimmel Cancer Center. , The link between persistent inflammation ... high-grade prostate cancer those with a Gleason score ... the most aggressive and rapidly growing prostate cancers. , ...
(Date:4/17/2014)... vaccine brands for children may not be the most ... factors when choosing vaccines, driving the market toward what ... new study by University of Illinois researchers. , "The ... numerous factors," says Sheldon H. Jacobson, a co-author of ... of mathematics at the U. of I. "In an ...
(Date:4/17/2014)... of California, San Diego School of Medicine report that ... a recent major loss are more likely to be ... study is published in this month,s issue of the ... compassionate behaviors are associated with better health and well-being ... ways to improve the outcomes of individuals whose deficits ...
Breaking Medicine News(10 mins):Health News:Benaroya Research Institute evaluates immunology approach to blocking breast cancer 2Health News:Innovative strategy to facilitate organ repair 2Health News:Innovative strategy to facilitate organ repair 3Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study recalculates costs of combination vaccines 2Health News:The ilk of human kindness 2
... the Bench,-, EL SEGUNDO, Calif., Oct. 16 ... solutions for microarray-based,research, announced today the release of ... that provides easy, fast and powerful platform,independent and ... data sets, simultaneously. NEXUS CGH easily supports ...
... The department of bioengineering at Clemson University has received ... Both the National Institutes of Health (NIH) and a ... (NSBRI www.nsbri.org ), are primary contributors of funds ... application. , The study addresses bone loss that occurs ...
... YORK, Oct. 16 Even though Americans pick up ... toothbrushes,may need a cleaning of their own. Celebrity Dentist ... says a new survey conducted by the,Philips Sonicare brand ... Listen to this report from Philips (NYSE: ...
... Unique Request Highlights December 2 Annual Wells Fargo Walk of Ages ... ... Home is,inviting everyone with the name of "Walker" in the United States to ... Walk of,Ages" on December 2 in Reseda. According to official census records there,are ...
... - BCL.P, VANCOUVER, Oct. 16 /PRNewswire-FirstCall/ ... announce that it has entered into an ... (the "Arrangement,Agreement") with iCo Therapeutics Inc. ("iCo"). ... constitute Beanstalk,s,"Qualifying Transaction" as a capital pool ...
... children appear to have a lower risk of asthma ... a non-agricultural rural environment, according to a University of ... 13,524 asthmafree children aged less than 12 years in ... Youth (NLSCY) showed that children living in a farming ...
Cached Medicine News:Health News:BioDiscovery Releases NEXUS CGH Version 2 for DNA Copy Number Analysis and Visualization 2Health News:Clemson awarded $2M to study radiation-induced bone loss 2Health News:FORGET THE JONESES, This is All About Keeping up With the Walkers as the Los Angeles Jewish Home Sends Out an Invite to Everyone Named 'Walker' in the United States 2Health News:Beanstalk Capital Ltd. enters into arrangement agreement with iCo Therapeutics Inc. 2Health News:Beanstalk Capital Ltd. enters into arrangement agreement with iCo Therapeutics Inc. 3Health News:Beanstalk Capital Ltd. enters into arrangement agreement with iCo Therapeutics Inc. 4Health News:Beanstalk Capital Ltd. enters into arrangement agreement with iCo Therapeutics Inc. 5Health News:Beanstalk Capital Ltd. enters into arrangement agreement with iCo Therapeutics Inc. 6Health News:Beanstalk Capital Ltd. enters into arrangement agreement with iCo Therapeutics Inc. 7Health News:Beanstalk Capital Ltd. enters into arrangement agreement with iCo Therapeutics Inc. 8Health News:Beanstalk Capital Ltd. enters into arrangement agreement with iCo Therapeutics Inc. 9Health News:Beanstalk Capital Ltd. enters into arrangement agreement with iCo Therapeutics Inc. 10Health News:Farm kids have lower risk of asthma, study shows 2
... ACMI™ offers five classes of resectoscope ... cutting loops, knife, roller bar & ... the only electrodes specifically integrated into ... tissue removal with minimal bleeding, increased ...
... new OES Pro System features a small ... Pediatric applications. With a reduced outer diameter ... new instrument can be used as a ... addition of an outer sheath (15.9Fr), it ...
ACMI™ S-Series Resectoscope Systems: Precision instruments designed for superior optical recognition, accurate control, and exceptional durability during steam autoclave sterilization....
... Rotating Continuous Flow Resectoscopes enhance ease of ... the working element and telescope to the ... result no rotating components in the ... rotating flow ports, simplifying procedures. The new ...
Medicine Products: